Regular colorectal cancer (CRC) screening may help
reduce mortality rates and has the potential to save lives
1

The U.S. Preventive Services Task Force (USPSTF) and the American Cancer Society (ACS) both recommend screening patients at average risk for CRC starting at age 45.1,2

(Grade B recommendation)1*

Of the ~44 million average-risk patients aged 45 and older eligible for CRC screening3:
~19 Million
Screening-eligible patients are aged 45 to 49 years3

Despite the American Cancer Society (ACS) lowering its initial screening age to 45 in 20182:

Only 1 in 5 patients aged 45 to 49 years recently reported screening for CRC4†
Initiating CRC screening at age 45 provides multiple benefits according to projection models, including averted CRC cases, a reduction in CRC-related deaths, and an increase in patient life-years gained.1
  • Incidence and severity in patients <50

    Among patients younger than 50 years:

    ~51%
    Increase in the incidence
    of CRC since 19942
    ~52%
    Were diagnosed with more
    advanced stages of CRC vs
    40% of patients aged 50+ years
    (2004-2015)5*
    *Retrospective study of National Cancer Database.5

Early detection of CRC is vital

0
Symptoms
Many patients with early-stage CRC
have no symptoms, making proactive
screening the only way to detect CRC6
90%
Survival Rate
The 5-year relative survival rate
(stages I and II)* is 90%, but when
diagnosed in stage IV, that number
drops to 15%7,8‡

5-year relative survival rates drastically diminish in later stages7,8§

5-year survival rates by stage of CRC7,8§:

90%
Stages I, IIa, IIb (Localized)7,8
72%
Stages IIc, III (Regional)7,8
15%
Stage IV (Distant)7,8

Unfortunately, more than half of patients are diagnosed with regional or distant disease.7||